Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans

Stroke

Volumn 30, Issue 7, 1999, Pages 1409-1416

  Thomas, Jeffrey E ^a,b   Rosenwasser, Robert H ^a   Armonda, Rocco A ^a   Harrop, James ^a   Mitchell, William ^a   Galaria, Irfan ^a  

^a WILLS EYE HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cerebral aneurysm; Human; Ischemia; Nitric oxide; Vasospasm

Indexed keywords

NIMODIPINE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; BRAIN VASOSPASM; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HUMAN; HYPOTENSION; INTRATHECAL DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL; REMISSION; SPASMOLYSIS; TREATMENT OUTCOME;

EID: 0033027409     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.7.1409     Document Type: Article

References (46)

1. Denny-Brown D. The treatment of recurrent cerebrovascular symptoms and the question of "vasospasm." Med Clin North Am. 1951;35: 1457-1474.
2. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol. 1983;14:599-608.
3. Wilkins RH. Attempts at prevention or treatment of intracranial arterial spasm: an update. Neurosurgery. 1986;18:808-825.
4. Kassell NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985;16: 562-572.
5. Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg. 1976;45:148-154.
6. Pritz MB, Giannotta SL, Kindt GW, McGillicuddy JE, Prager RL. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery. 1978;3:364-368.
7. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11: 337-343.
8. Wood JH, Simeone FA, Fink EA, Golden MA. Hypervolemic hemodilution in experimental focal cerebral ischemia: elevation of cardiac output, regional cortical blood flow and ICP after intravascular volume expansion with low molecular weight dextran. J Neurosurg. 1983;59:500-509.
9. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619-624.
10. Fujiwara S, Kassell NF, Sasaki T, Nakagomi T, Lehman RM. Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. J Neurosurg. 1986;64:445-452.
11. Kanamaru K, Waga S, Kojima T, Fujimoto K, Niwa S. Endothelium-dependent relaxation of canine basilar arteries, part 2: inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke. 1987;18:938-943.
12. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Ogawa H, Vollmer D, Lehman RM. Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg. 1988;69:247-253.
13. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res. 1992;40:248-256.
14. Egemen N, Turker RK, Sanlidilek U, Zorlutuna A, Bilgic S, Baskaya M, Unlu A, Caglar S, Spetzler RF, McCormick JM. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res. 1993;15: 310-315.
15. Thomas JE, Zelman V, Giannotta SL. Reversal of endothelin-induced cerebral vasoconstriction by sodium nitroprusside. J Neurosurg. 1996; 84:329. Abstract.
16. Thomas JE, Nemirovsky A, Zelman V, Giannotta SL. Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery. 1997;40:1245-1249.
17. Thomas JE, Armonda RA, Rosenwasser RH. Reversal of severe cerebral vasospasm in a patient following aneurysmal subarachnoid hemorrhage: preliminary observations on the use of intrathecal nitric oxide donors in humans. J Neurosurg. 1998;88:198A. Abstract.
18. Thomas JE, Armonda RA, Morrison S, Rosenwasser RH. Preliminary report: initial observations on the safety and efficacy of intrathecal nitric oxide donors for the treatment of refractory cerebral vasospasm and ischemia in humans. Neurosurgery. 1998;43:670. Abstract.
19. Thomas JE, Rosenwasser RH. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery. 1999;44:48-58.
20. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14-20.
21. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computed tomographic scanning. Neurosurgery. 1980;6:1-9.
22. Bagley C. Blood in the cerebrospinal fluid: experimental data. Arch Surg. 1928;17:18-38.
23. Jackson I. Aseptic hemogenic meningitis: an experimental study of aseptic meningeal reactions due to blood and its breakdown products. Arch Neurol Psychiatry. 1949;62:572-589.
24. Thomas JE. Molecular biological considerations in cerebral vasospasm following aneurysmal subarachnoid hemorrhage [serial online]. Neurosurg Focus. 1997;3. Article 3.
25. Eskridge JM, McAuliffe W, Song JK, Dwliganis AV, Newell DW, Mayberg MR, Winn HR. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998;42:510-516.
26. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
27. Fuwa I, Mayberg M, Gadjusek C, Harada T, Luo Z. Enhanced secretion of endothelin by endothelial cells in response to hemoglobin. Neurol Med Chir (Tokyo). 1993;33:739-743.
28. Kasuya H, Weir BK, White DM, Stefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg. 1993;79:892-898.
29. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg. 1992;77:274-278.
30. Gibson QH, Roughton FJW. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol (Lond). 1957;136: 507-526.
31. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985;232:708-716.
32. Fujiwara S, Kassell NF, Sasaki T, Nakagomi T, Lehman RM. Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. J Neurosurg. 1986;64:445-452.
33. Kanamaru K, Waga S, Kojima T, Fujimoto K, Niwa S. Endothelium-dependent relaxation of canine basilar arteries, part 2: inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke. 1987;18:938-943.
34. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg. 1978;48:173-178.
35. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376.
36. Heros RC, Zervas NT, Lavyne MH, Pickren KS. Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy. Surg Neurol. 1976;6:227-229.
37. Allen GS. Cerebral arterial spasm, part 8: the treatment of delayed cerebral arterial spasm in human beings. Surg Neurol. 1976;6:71-80.
38. Hirsh LF. Intra-arterial nitroprusside treatment of acute experimental vasospasm. Stroke. 1980;11:601-605.
39. Afshar JKB, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1995;83:118-122.
40. Raynor RB, McMurtry JG. Prevention of serotonin-produced cerebral vasospasm: an evaluation of blocking agents. J Neurosurg. 1963;20: 94-96.
41. Heros RC, Zervas NT, Negoro M. Cerebral vasospasm. Surg Neurol. 1976;5:354-362.
42. Culotta E, Koshland DE. NO: molecule of the year. Science. 1992;258: 1862-1865.
43. Wolf Erich W, Banerjee Amit, Soble-Smith Jill. Dohan F. Curtis Jr, White Richard P, Robertson James T. Reversal of cerebral vasospasm using an intrathecally-administered nitric oxide donor. J Neurosurg. 1998;89:279-288.
44. Smith RP, Kruszyna H. Nitroprusside produces cyanide poisoning via a reaction with hemoglobin. J Pharm Exp Ther. 1974;191:557.
45. Crockard HA, Brown FD, Mullan JF. Effects of trimethaphan and sodium nitroprusside on cerebral blood flow in rhesus monkeys. Acta Neurochir. 1976; 35:85-89.
46. Weiss MH, Spence J, Apuzzo ML, Heiden JS, McComb JG, Kurze T. Influence of nitroprusside on cerebral pressure autoregulation. Neurosurgery. 1979;4:56-59.